Related Experiment Videos
Role of controlled septal infarct in hypertrophic obstructive cardiomyopathy
Christopher D Nielsen1, William H Spencer
1Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Insights
Nonsurgical septal reduction therapy, or alcohol septal ablation, effectively reduces left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy. This minimally invasive procedure offers symptom improvement with manageable risks and positive long-term effects on myocardial function.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Hypertrophic obstructive cardiomyopathy (HOCM) presents significant clinical challenges.
- Existing treatments like medical, surgical, and pacing therapies offer variable success rates.
- Percutaneous catheter-based interventions are emerging as alternative treatment modalities.
Purpose of the Study:
- To evaluate the efficacy and safety of nonsurgical septal reduction therapy (alcohol septal ablation) for HOCM.
- To assess the impact of alcohol septal ablation on left ventricular outflow tract (LVOT) obstruction and patient symptoms.
- To investigate the procedural complications and long-term effects on cardiac structure and function.
Main Methods:
- Alcohol septal ablation performed percutaneously via catheter.
- Assessment of left ventricular outflow tract gradient reduction.
- Evaluation of symptom improvement and diastolic function.
- Monitoring for complications, particularly complete heart block requiring pacemaker implantation.
Main Results:
- Significant reductions in LVOT gradient observed post-procedure.
- Marked improvement in patient symptoms reported.
- Low procedural risk with refinements in technique mitigating common complications like heart block.
- Demonstrated improvements in diastolic function, decreased left ventricular hypertrophy and mass.
- Cellular and molecular changes contributing to improved myocardial function.
Conclusions:
- Nonsurgical septal reduction therapy is an effective treatment for HOCM, improving LVOT obstruction and symptoms.
- The procedure is associated with relatively low risk, with improved management of complications.
- Alcohol septal ablation positively impacts cardiac structure and function, with sustained benefits observed at 1-year follow-up.
- Ongoing long-term studies are crucial to further elucidate the durability and full impact of this therapy.
Abstract:
Hypertrophic obstructive cardiomyopathy is a complex and challenging disease. Medical therapy, surgical therapy, and pacing therapy have been used with some success over the years. Nonsurgical septal reduction therapy, also called alcohol septal ablation, has been used recently as a percutaneous catheter-based intervention to improve left ventricular outflow tract obstruction and thereby improve symptoms. The reported results of this procedure have shown impressive reductions in gradient and improvement in symptoms at relatively low risk. The most common complication of the procedure, development of complete heart block requiring a permanent pacemaker, has improved in recent studies with refinements of the procedural technique. Nonsurgical septal reduction therapy has been shown to improve diastolic function, decrease left ventricular hypertrophy and mass, and cause changes at the cellular and molecular level that improve myocardial function. Reported results at 1 year follow-up continue to show benefit, and long-term studies are ongoing.